Contrary to differences in Aβ deposition observed between pathological groups, amounts of phosphorylated tau (pTau) deposits only showed minor differences across the groups of AD cases (sAD, DS-AD, APPdup, and APP missense mutations V717L and V717I). This evidence concerns the gene MAPT and Dravet syndrome.